But look at other biotech stocks listed on NASDAQ or NYSE when they put in an IND they show preclinical work and are approved immediately for testing. The fact that BMSN has to submit more data is not good as the FDA was not satisfied with current data! IMUC submitted their IND and got approval by FDA immediately after only one submission.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.